Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.2B | 7.4B | 8.2B | 7.2B |
| Cost of revenue | 4.0B | 3.5B | 4.1B | 3.6B |
| Gross profit | 4.3B | 3.9B | 4.0B | 3.5B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | 2.3B | 2.1B | 2.1B | 1.7B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 889M | 871M | 872M | 824M |
| Other income expense | 149M | 36M | 193M | 151M |
| Pretax income | 1.6B | 1.3B | 1.5B | 1.1B |
| Tax provision | 193M | 109M | 163M | 140M |
| Net income | 1.4B | 1.2B | 1.3B | 921M |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | 4.2B | 3.6B | 4.0B | 3.5B |
| Net income from continuing op. | 1.4B | 1.2B | 1.3B | 921M |
| Minority interests | -25M | -22M | -34M | -21M |
| Preferred stock dividends | — | 0 | 16M | — |